Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2019 November;85(11) > Minerva Anestesiologica 2019 November;85(11):1159-67

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

ORIGINAL ARTICLE   Freefree

Minerva Anestesiologica 2019 November;85(11):1159-67

DOI: 10.23736/S0375-9393.19.13522-5

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

The prognostic role of red blood cell distribution width in transfused and non-transfused critically ill patients

Alberto FOGAGNOLO 1, Savino SPADARO 1 , Fabio S. TACCONE 2, Riccardo RAGAZZI 1, Anna ROMANELLO 1, Alberto FANNI 1, Elisabetta MARANGONI 1, Federico FRANCHI 3, Sabino SCOLLETTA 3, Carlo A. VOLTA 1

1 Unit of Anesthesia and Intensive Care, Department of Morphology, Experimental Medicine and Surgery, Sant’Anna University Hospital, University of Ferrara, Ferrara, Italy; 2 Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; 3 Department of Medical Biotechnologies, Anesthesiology and Intensive Care, University Hospital of Siena, Siena, Italy



BACKGROUND: Red blood cell distribution width (RDW) value is gaining popularity as a prognostic factor in critically ill patients. However, its role in transfused patients is unclear. The aim of this study was to evaluate the predictive value of Red blood cell distribution width (RDW) on Intensive Care Unit (ICU) admission for 90-day mortality among either transfused or non-transfused critically ill patients.
METHODS: This observational cohort study includes 286 patients with at least 48 hours of ICU length of stay. Patients were analyzed separately in two groups, depending on whether or not they were transfused in the last 72 hours before ICU admission.
RESULTS: One hundred seventeen (117) patients (41%) were transfused. Patients with high RDW on admission (N.=181, 63%) had higher 90-day mortality both in non-transfused (26/87, 30% vs. 12/82, 14% P=0.03) or transfused (39/94, 41% vs. 2/23, 8% P=0.003) patients. The area under the curve of admission RDW values to predict 90-day mortality was 0.660 and 0.610 for non-transfused and transfused patients, respectively. The Youden Index analysis showed that an RDW value of 14.3% was the best cut-off to predict mortality in the non-transfused group, while 15.3% was the best cut-off in the transfused group.
CONCLUSIONS: High RDW values on ICU admission are independently associated with 90-day mortality in critically ill patients regardless of previous red blood cells transfusion. However, we identified two different cut-offs of “high RDW” to be used in ICU in transfused and non-transfused patients.


KEY WORDS: Erythrocyte indices; Erythrocyte transfusion; Biomarkers; Mortality; Critical illness

top of page